Public Interest Comment on the DEA Proposed Rules on Telemedicine and Buprenorphine
Improving access to opioid use disorder treatments by making permanent pandemic-era flexibilities
Public Interest Comment on the DEA Proposed Rules on Telemedicine and Buprenorphine
Improving access to opioid use disorder treatments by making permanent pandemic-era flexibilities
Jimmy Carter, the Great Deregulator
The regulatory reforms of President Jimmy Carter set in motion a wave of deregulation that brought lower prices and better consumer choices to key industries
Beyond Republicans and the Disapproval of Regulations
Contrary to conventional wisdom, the Congressional Review Act has been used by both U.S. political parties to nullify regulations
Highlights from the SBCA 2023 Annual Conference
The Regulatory Studies Center team was delighted to participate in the SBCA annual conference, featuring perspectives and research on benefit-cost analysis.
Merger Law Is Dante’s Inferno Revisited
The shift by agencies away from the current guidelines on mergers and acquisitions has left firms in limbo.
Federal Railroad Administration has not identified a compelling public need for its proposed rule on minimum crew size
Making State Level Regulation More Accountable
Virginia's new guidelines aim to streamline its state-level regulatory red tape by 25% and could serve as a useful model for other states.
Broadening Public Engagement in the Federal Regulatory Process
Public interest comment with input on public engagement initiatives by the Office of Information and Regulatory Affairs
OIRA’s public engagement recommendations have the opportunity to expand engagement in the federal rulemaking process
FTC Commissioner Wilson’s Noisy Resignation
GW Law Professor Richard J. Pierce on accusations of unethical and unconstitutional behavior by the FTC Chair